Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...
SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
Childhood hypertension affects a substantial and growing proportion of the global paediatric population, with prevalence ...
Meta-analysis of diagnostic test accuracy studies is an increasingly pivotal approach in evidence-based medicine, enabling the synthesis of data from multiple investigations to assess the performance ...
Objective To investigate the occurrence of unintentional injuries among children aged 3 to 12 in China over the past 5 years, and to provide a scientific basis for the prevention and control of such ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a new ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...
In the study, Raza and colleagues reviewed data from 214 adults who underwent BLVR at a single center between January 2018 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback